Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Birinapant

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Birinapant clinical study initiated by IGM Biosciences
    Birinapant clinical study initiated by IGM Biosciences

    04 Nov 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/birinapant-clinical-study-initiated-by-igm-biosciences-301416698.html

    PRNEWSWIRE
    04 Nov 2021
    Share Share
    IGM Biosciences Enters into Exclusive Agreement with Medivir for Birinapant
    IGM Biosciences Enters into Exclusive Agreement with Medivir for Birinapant

    12 Jan 2021

    // GLOBENEWSWIRE

    http://www.globenewswire.com/news-release/2021/01/11/2156664/0/en/IGM-Biosciences-Enters-into-Exclusive-Licensing-Agreement-with-Medivir-for-Birinapant.html

    GLOBENEWSWIRE
    12 Jan 2021
    Share Share
    Medivir strengthens its business development possibilities through renegotiated
    Medivir strengthens its business development possibilities through renegotiated

    11 Dec 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/medivir-strengthens-its-business-development-possibilities-through-a-renegotiated-agreement-with-tetralogic-regarding-birinapant-301191026.html

    PRNEWSWIRE
    11 Dec 2020
    Share Share
    Futility Analysis Performed the Ph II CombO Study with Birinapant and Keytruda
    Futility Analysis Performed the Ph II CombO Study with Birinapant and Keytruda

    16 Dec 2019

    // BUSINESS WIRE

    https://www.prnewswire.com/news-releases/futility-analysis-performed-of-the-phase-ii-combination-study-with-birinapant-and-keytruda-in-colorectal-cancer-patients-300975351.html

    BUSINESS WIRE
    16 Dec 2019
    Share Share
    New Data From the PhI Study of Birinapant in Combination With Keytruda® ASCO
    New Data From the PhI Study of Birinapant in Combination With Keytruda® ASCO

    16 May 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-data-from-the-phase-i-study-of-birinapant-in-combination-with-keytruda-will-be-presented-at-the-asco-2019-300851466.html

    PR NEWSWIRE
    16 May 2019
    Share Share